Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Momordica charantia leaf
Leaves of bitter melon used in Ayurveda separately from the fruit for liver, skin, and antiparasitic conditions.
Karela leaf (Momordica charantia) is a traditional Ayurvedic herb used for liver support, skin conditions, and intestinal parasites. Its active compounds include momordicin, charantin, lectins, and polypeptide-p, which contribute to hepatoprotective, antimicrobial, and hypoglycemic effects. Modern research supports its use in blood glucose modulation, though evidence is limited to small studies (Level C).
Momordicin and charantin act as bitter principles that stimulate digestive secretions and enhance hepatic detoxification pathways, potentially via upregulation of phase II enzymes. Lectins may bind to intestinal epithelial cells, exerting antiparasitic and immunomodulatory effects. Polypeptide-p (plant insulin) appears to mimic insulin activity or enhance peripheral glucose uptake, possibly through activation of AMPK and PPARγ pathways. Beta-sitosterol contributes anti-inflammatory and cholesterol-lowering actions by inhibiting intestinal cholesterol absorption and modulating cytokine release.
Leaves of bitter melon used in Ayurveda separately from the fruit for liver, skin, and antiparasitic conditions.
Karela leaf (Momordica charantia) is a traditional Ayurvedic herb used for liver support, skin conditions, and intestinal parasites. Its active compounds include momordicin, charantin, lectins, and polypeptide-p, which contribute to hepatoprotective, antimicrobial, and hypoglycemic effects. Modern research supports its use in blood glucose modulation, though evidence is limited to small studies (Level C).
Momordicin and charantin act as bitter principles that stimulate digestive secretions and enhance hepatic detoxification pathways, potentially via upregulation of phase II enzymes. Lectins may bind to intestinal epithelial cells, exerting antiparasitic and immunomodulatory effects. Polypeptide-p (plant insulin) appears to mimic insulin activity or enhance peripheral glucose uptake, possibly through activation of AMPK and PPARγ pathways. Beta-sitosterol contributes anti-inflammatory and cholesterol-lowering actions by inhibiting intestinal cholesterol absorption and modulating cytokine release.